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12h00 – 12h40 Lunch and registration 
12h40 – 12h45 Welcome by the president 
 
12H45-13H25 INVITED LECTURE  
 CHAIR: J. NORTIER, ERASME BRUSSELS - K. CLAES, UZ LEUVEN   
 Pathophysiology and clinical manifestations of cardiovascular calcifications in CKD 
 M. Ketteler, Medical School Regiomed Coburg , Deutschland 
 
13H25 – 14H15 FREE COMMUNICATIONS I 
 CHAIR: J. NORTIER, ERASME BRUSSELS – M. MARCHAL, CHU TIVOLI 
13h25 – 13h35 Administration of Third-Party Mesenchymal Stromal Cells at the Time of Kidney Transplantation: Interim 
 Safety Analysis at One-Year Follow-Up 
 P. Erpicum, L. Weekers, O. Detry, C. Bonvoisin, C. Lechanteur, A. Briquet, E. Baudoux, F. Jouret, Y. Beguin 
13h35 – 13h45 Myeloid heme oxygenase-1 controls renal ischemia reperfusion injury 
 M. Rossi, A. Thierry, S. Delbauve, O. Leo, T. Roumeguère, V. Flamand, A. Le Moine,  J.M. Hougardy 
13h45 – 13h55 L-Arginine supplementation reduces fibrosis in a mouse model of chronic aristolochic acid induced 
 nephropathy 
 I. Jadot, V. Colombaro, B. Martin, I. Habsch, O. Botton, J. Nortier, A-E Declèves, N. Caron  
13h55 – 14h05 Protective effects of Pistacia lentiscus seed extract against calcium oxalate monohydrate induced proximal 
 tubular injury 
 N. Cheraft, C. Husson, D. Atmani, C. Stevigny, J. Nortier, M.H. Antoine 
14h05 – 14h15 Estimated GFR poorly reflects the concentration of various uremic toxins in pediatric CKD patients 
 E. Snauwaert, G. Glorieux,W. Van Biesen, A. Raes, J. Vande Walle, S. Eloot 
 
14H15 – 14H27 BULLETS 
 CHAIR: J.L. BOSMANS, UZ ANTWERPEN – N. KANAAN, UCL BRUSSELS 
14h15 – 14h19 Balkan endemic nephropathy studied in a metabonomic context: preliminary results 
 M. Duquesne, Z. Dika, B. Jelakovic, E. De Prez, J.M. Colet, J. Nortier 
14h19 – 14h23 Concentrations of representative uremic toxins in a healthy versus uremic pediatric population 
 E. Snauwaert, G. Glorieux, V. Van Bogaert, W. Van Biesen, A. Raes, J. Vande Walle, S. Eloot 
14h23 – 14h27 Predicting death in elderly people with or without advanced chronic kidney disease: a systematic review of risk 
 prediction models 
 M. Stryckers, I. Nistor, W. Van Biesen, E. Nagler 
 
14H27 – 15H07 INVITED LECTURE  
 CHAIR: J.L. BOSMANS, UZ ANTWERPEN – M. MARCHAL, CHU TIVOLI  
 Home dialysis therapies: benefits and perspectives  
 E. Goffin, UCL Bruxelles 
 
15H07 – 15H45 BREAK 
 
15H45– 16H05  CASE REPORT 
 CHAIR: J.L. BOSMANS, UZ ANTWERPEN  
15h45– 15h55 A curious case of recurrent culture negative PD peritonitis 
 P-J. Van Gaal, K. Bouman, K. De Boeck, H. Hoeben, E. De Droogh,  M. Helbert 
15h55– 16h05 Bilateral Renal Vein Thrombosis in the newborn  
 A. De Bruyne, N. Godefroid, N. Ranguelov, A. Van Damme 
 
 
 16H05 – 17H35 FREE COMMUNICATIONS II 
 CHAIR: S. VAN LAECKE, UZ GENT – F. JOURET, CHU DE LIÈGE 
16h05 – 16h15 KDRI implementation: could this lead to the transplantation of more and higher-quality donor kidneys? 
 E. Philipse, B. Bracke, V. Hartman, K. De Greef, T. Chapelle, G. Roeyen, D. Ysebaert, V. de Meyer, C. Seghers, L. 
 Georgieva, M.-M. Couttenye, J.-L. Bosmans, D. Abramowicz 
16h15 – 16h25 Evolution of renal function in a large cohort of HIV positive patients treated with  highly active antiretroviral 
 therapy: a retrospective cohort study  
 N. Lamine, M. Garjau, M. Delforge, S. De Wit, K.M. Wissing 
16h25 – 16h35 3D-US with a correction factor is a good alternative in estimating total kidney volume in children with 
 Autosomal Dominant Polycystic Kidney Disease 
 S. De Rechter, L. Breysem, M. Smet, F. De Keyzer, M. Van Dyck, B. Bammens, R. Oyen, E. Levtchenko, D. Mekahli 
16h35– 16h45 Citrate-based locking solutions are more efficient than Taurolidine-based locking solutions to prevent 
 thrombotic dysfunction of tunnelled hemodialysis catheters: a retrospective cohort study 
 F. Van Hulle, F. Bonkain, C. Tielemans, D. De Clerck, P. Janssens, L. Pipeleers, N. Van Paesschen, M. Roden, K.M. Wissing 
16h45– 16h55 Efficacy of thrombolysis with urokinase containing locking solutions for thrombotic dysfunction of tunnelled 
 hemodialysis catheters: a retrospective single-centre cohort study   
 F. Van Hulle, F. Bonkain, C. Tielemans, D. De Clerck, P. Janssens, L. Pipeleers, N. Van Paesschen, M. Roden, K.M. Wissing 
16h55– 17h05  Outcomes of Kidney Transplantation in Children Weighing ≤15 Kg  
 B. Chiodini, J. Herman, K. Lolin, B. Adams, E. Hennaut,P. Lingier, M. Hall, F. Janssens, R. Van Damme-
 Lombaerts, N. Knops, K.M. Wissing, K. Ismaili 
17h05– 17h15 Hyponatremia is a marker of severity 
 P. Braconnier, M. Delforge, M. Garjau, K.M. Wissing, S. De Wit 
17h15– 17h25 HemodiaFiltration with endogenous Reinfusion of ultrafiltrate (HFR) vs high-flux hemodialysis: discrepancies in 
 depuration of middle molecular  weight proteins 
 I. Simon, C. Husson, K. Gastaldello, J. Racape, K. Zouaoui Boudjeltia, C. Lelubr5, C. Gervy,J .Nortier 
17h25– 17h35  Smoking history and delayed graft function in renal transplant recipients: an observational cohort study 
 S. Van Laecke, E. Nagler,  F. Verbeke, C. Randon, F. Vermassen, P. Peeters, W. Van Biesen 
 
17H35– 17H47 BULLETS 
  CHAIR: J.L. BOSMANS, UZ ANTWERPEN 
17h35– 17h39  Outcome after arteriovenous fistula creation: a single center experience from Belgium 
 C. Catalano, M. Garjau, M. Savino, C. Schreiter, Y. Dernier, M. Laureys, R. Wens,  P. Beaurain, C. Defawe,  
 M. Standaert M, K.M. Wissing 
17h39– 17h43  The Uptake of 18F-FDG by Renal Allograft in Kidney Transplant Recipients is not Influenced by Renal Function 
 A. Jadoul, P. Lovinfosse, L. Weekers, P. Delanaye, J.M. Krzesinski, R. Hustinx, F. Jouret 
17h43– 17h47  Online survey exploring opinions of European pediatric/adults nephrologists  and geneticists about diagnostic 
 testing of  asymptomatic offspring from families affected by Autosomal Dominant Polycystic Kidney Disease  
 D. Mekahli, S. De Rechter, J. Kringen, A. Serra, K. Devriendt, E. Levtchenko, C. Bergmann, B. Bammens,  
 P. Borry, F. Schaefer 
 
17H47– 18H10 INVITED 
17h47 – 18h00  Reflection BCCCN 
 P. Peeters, UZ Gent  
18h00 – 18h10  Biosimilars in nephrology 
 J. Nortier, Hôpital Erasme Brussels 
 
18H10 - 18H20 CLOSING REMARKS - AWARDS AND FAREWELL 
 J. Nortier 
 
18H20 – 18H35 GENERAL ASSEMBLY BVN-SBN MEMBERS  
